跳至主要内容
临床试验/NCT01682993
NCT01682993终止3 期

Topography Guided Excimer Laser Surface Ablation in Combination With Corneal Cross-linking (CCL) in Patients With Progressive Ectatic Corneal Disorders.

Medical University of Vienna2 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2010年1月最近更新:
适应症

试验速览

阶段
3 期
状态
终止
入组人数
30
试验地点
2
主要终点
Safety (Pachymetry, K-readings)

研究概览

简要总结

Topography guided laser treatment enables the surgeon to correct higher order aberrations in corneas with irregular astigmatism. Several case reports and small uncontrolled trials have been published on the combination of this treatment with corneal cross linking (CCL) in patients with ectatic corneal diseases.

This randomized study will evaluate the safety and efficacy of a combined treatment of corneal cross linking with a partial topography guided excimer laser treatment in eyes with progressive ectatic corneal diseases.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 40 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Signed informed consent
  • Patient age 18 - 40 years
  • Documented progressive corneal ectatic disease except post LASIK/LASEK ectasia

排除标准

  • Allergy to one of the used substances
  • Tendency towards excessive scar formation
  • Pregnancy
  • Rheumatic diseases
  • Central corneal thickness below 450 µm
  • Active infection of the study eye
  • Previous corneal surgery of the study eye

结局指标

主要结局

Safety (Pachymetry, K-readings)

时间窗: 1 year

uncorrected visual acuity (UVCA)

时间窗: 1 year

best corrected visual acuity (BCVA)

时间窗: 1 year

次要结局

  • Progression of ectatic disease (by use of maximum keratometry readings = Kmax)(1 year)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Gerald Schmidinger

MD, Assistant Professor

Medical University of Vienna

研究点 (2)

Loading locations...

相似试验